FDA Approval of Bosulif Adds to Toolkit of Treatment Options for Children With CML
The Food and Drug Administration (FDA) has approved Bosulif (bosutinib) for the treatment of children as young as 1 year old with newly...
Oct 10, 2023
It Takes a Lifetime to Survive Childhood Cancer
"Fending off early death is a victory. What the next four or five decades are like remains a challenge, for patients and families and...
Oct 6, 2023
Host genetics helps explain childhood cancer survivors’ mortality risk from second cancers
Using data from the Childhood Cancer Survivor Study (CCSS) and the St. Jude Lifetime Cohort Study (St. Jude Life), scientists at St....
Oct 5, 2023
We’re missing a critical opportunity to prevent childhood cancer
This is a real, rapid increase in childhood cancer rates. If it’s not a result of genes or behavior, it’s likely caused by something in...
Oct 4, 2023
Intensive Treatment May Pose Fertility Risks in Childhood Cancer Survivors
Intensive therapies such as hematopoietic stem cell transplantation (HSCT) and high-dose testicular radiation doses during puberty may...
Oct 3, 2023